Relationship of body mass index and prostate specific antigen in a population-based study

Ian M Thompson; Robin Leach; Dean Troyer; Brad Pollock; Susan Naylor; Betsy Higgins

doi:10.1016/S1078-1439(03)00171-6

Relationship of body mass index and prostate specific antigen in a population-based study

Ian M Thompson, Robin Leach, Dean Troyer, Brad Pollock, Susan Naylor, Betsy Higgins

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

This study was designed to use a prospectively analyzed, population-based, multiethnic cohort of men to determine if there is a relationship between one measure of obesity/overweight (Body Mass Index) and Prostate Specific Antigen (PSA). A total of 1565 men without a prior diagnosis of prostate cancer were prospectively enrolled in the San Antonio study of Biomarkers Of Risk (SABOR) Clinical and Epidemiologic Center of the Early Detection Research Network of the National Cancer Institute. Body Mass Index (BMI) was compared with serum PSA levels, stratifying by ethnic group. No relationship was found between BMI and PSA in any ethnic group or in the cohort as a whole. This study suggests that there is no increased risk of overdetection of prostate cancer among obese men due to an elevation in PSA.

Original language	English (US)
Pages (from-to)	127-131
Number of pages	5
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	22
Issue number	2
DOIs	https://doi.org/10.1016/S1078-1439(03)00171-6
State	Published - Mar 2004

Keywords

Body Mass Index
Cancer risk
Prostate Specific Antigen
Prostate cancer

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/S1078-1439(03)00171-6

Cite this

@article{253070cbd4a74c6495455812de9554f1,

title = "Relationship of body mass index and prostate specific antigen in a population-based study",

abstract = "This study was designed to use a prospectively analyzed, population-based, multiethnic cohort of men to determine if there is a relationship between one measure of obesity/overweight (Body Mass Index) and Prostate Specific Antigen (PSA). A total of 1565 men without a prior diagnosis of prostate cancer were prospectively enrolled in the San Antonio study of Biomarkers Of Risk (SABOR) Clinical and Epidemiologic Center of the Early Detection Research Network of the National Cancer Institute. Body Mass Index (BMI) was compared with serum PSA levels, stratifying by ethnic group. No relationship was found between BMI and PSA in any ethnic group or in the cohort as a whole. This study suggests that there is no increased risk of overdetection of prostate cancer among obese men due to an elevation in PSA.",

keywords = "Body Mass Index, Cancer risk, Prostate Specific Antigen, Prostate cancer",

author = "Thompson, {Ian M} and Robin Leach and Dean Troyer and Brad Pollock and Susan Naylor and Betsy Higgins",

note = "Funding Information: Supported by NCI grant #5U01CA86402-04. ",

year = "2004",

month = mar,

doi = "10.1016/S1078-1439(03)00171-6",

language = "English (US)",

volume = "22",

pages = "127--131",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Relationship of body mass index and prostate specific antigen in a population-based study

AU - Thompson, Ian M

AU - Leach, Robin

AU - Troyer, Dean

AU - Pollock, Brad

AU - Naylor, Susan

AU - Higgins, Betsy

N1 - Funding Information: Supported by NCI grant #5U01CA86402-04.

PY - 2004/3

Y1 - 2004/3

N2 - This study was designed to use a prospectively analyzed, population-based, multiethnic cohort of men to determine if there is a relationship between one measure of obesity/overweight (Body Mass Index) and Prostate Specific Antigen (PSA). A total of 1565 men without a prior diagnosis of prostate cancer were prospectively enrolled in the San Antonio study of Biomarkers Of Risk (SABOR) Clinical and Epidemiologic Center of the Early Detection Research Network of the National Cancer Institute. Body Mass Index (BMI) was compared with serum PSA levels, stratifying by ethnic group. No relationship was found between BMI and PSA in any ethnic group or in the cohort as a whole. This study suggests that there is no increased risk of overdetection of prostate cancer among obese men due to an elevation in PSA.

AB - This study was designed to use a prospectively analyzed, population-based, multiethnic cohort of men to determine if there is a relationship between one measure of obesity/overweight (Body Mass Index) and Prostate Specific Antigen (PSA). A total of 1565 men without a prior diagnosis of prostate cancer were prospectively enrolled in the San Antonio study of Biomarkers Of Risk (SABOR) Clinical and Epidemiologic Center of the Early Detection Research Network of the National Cancer Institute. Body Mass Index (BMI) was compared with serum PSA levels, stratifying by ethnic group. No relationship was found between BMI and PSA in any ethnic group or in the cohort as a whole. This study suggests that there is no increased risk of overdetection of prostate cancer among obese men due to an elevation in PSA.

KW - Body Mass Index

KW - Cancer risk

KW - Prostate Specific Antigen

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=1842786009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842786009&partnerID=8YFLogxK

U2 - 10.1016/S1078-1439(03)00171-6

DO - 10.1016/S1078-1439(03)00171-6

M3 - Article

C2 - 15082010

AN - SCOPUS:1842786009

SN - 1078-1439

VL - 22

SP - 127

EP - 131

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 2

ER -

Relationship of body mass index and prostate specific antigen in a population-based study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this